Loading...
Loading...
RXST| Name | Value |
|---|---|
| Revenues | 17.5M |
| Cost of Revenue | 7.1M |
| Gross Profit | 10.4M |
| Operating Expense | 23.5M |
| Operating I/L | -13.1M |
| Other Income/Expense | -0.1M |
| Interest Income | 1.4M |
| Pretax | -13.2M |
| Income Tax Expense | 1.6M |
| Net Income/Loss | -14.8M |
RxSight, Inc. is a medical technology company specializing in light adjustable intraocular lenses (LAL) for cataract surgery. Its flagship product, the RxSight system, allows doctors to customize and enhance visual acuity for patients post-surgery. The system comprises the RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed. This technology enables cataract doctors to offer personalized vision correction, providing a unique value proposition in the cataract surgery market.
